QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ineck, B. A Articles by Ng, T. M. Search for Related Content PubMed PubMed Citation Articles by Ineck, B. A Articles by Ng, T. M.

DRUG INFORMATION ROUNDS

Effects of Subclinical Hypothyroidism and its Treatment on Serum Lipids

Assistant Professor, Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, NE

Tien MH Ng, PharmD BCPS

Assistant Professor, Department of Pharmacy Practice, University of Nebraska Medical Center

Reprints: Tien MH Ng PharmD BCPS, Department of Pharmacy Practice, University of Nebraska Medical Center, 986045 Nebraska Medical Center, Omaha, NE 68198-6045, FAX 402/559-5673, E-mail tng{at}unmc.edu

OBJECTIVE: To determine whether the literature supports an effect of subclinical hypothyroidism on serum lipids and, if so, what are the effects of thyroxine replacement therapy.

DATA SOURCES: Articles were identified on MEDLINE using the MeSH terms hypothyroidism, lipids, or cholesterol.

DATA SYNTHESIS: The majority of studies that determined the prevalence of lipid abnormalities in subclinical hypothyroidism and studies that evaluated the effects of thyroxine replacement on lipids were small, uncontrolled, and varied in inclusion criteria. Six randomized, placebo-controlled trials were identified that evaluated the effect of levothyroxine on lipids in subclinically hypothyroid patients.

CONCLUSIONS: Subclinical hypothyroidism can potentially contribute to a pro-atherogenic lipid profile, with effects being greater at higher thyroid-stimulating hormone levels. Thyroxine replacement reduces total cholesterol and low-density lipoprotein cholesterol, with no effect on triglycerides. Effects on high-density lipoprotein, lipoprotein (a), and apolipoproteins A1 and B require further study. Larger prospective studies are needed to clarify many issues.

Key Words: hypothyroidism, levothyroxine, lipids

Published Online, March 25, 2003. www.theannals.com, DOI 10.1345/aph.1C376

This article has been cited by other articles:

				C. B Pham and A. F Shaughnessy Should we treat subclinical hypothyroidism? BMJ, July 16, 2008; 337(jul16_3): a834 - a834. [Full Text]

				S. Ardoin, C. Sandborg, and L. Schanberg Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 618 - 626. [Abstract] [PDF]

				S. Razvi, L. Ingoe, G. Keeka, C. Oates, C. McMillan, and J. U. Weaver The Beneficial Effect of L-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1715 - 1723. [Abstract] [Full Text] [PDF]

				M. I. Surks, G. Goswami, and G. H. Daniels The Thyrotropin Reference Range Should Remain Unchanged J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5489 - 5496. [Abstract] [Full Text] [PDF]

				P. B. Samollow, G. Perez, C. M. Kammerer, D. Finegold, P. W. Zwartjes, L. M. Havill, A. G. Comuzzie, M. C. Mahaney, H. H. Goring, J. Blangero, et al. Genetic and Environmental Influences on Thyroid Hormone Variation in Mexican Americans J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3276 - 3284. [Abstract] [Full Text] [PDF]